Financial Data and Key Metrics Changes - The GAAP net loss for Q3 2021 was $4.2 million, or $0.19 per share, compared to a net loss of $3.6 million, also $0.19 per share, in Q3 2020 [22][23] - Sequentially, the GAAP net loss increased from $3.7 million in Q2 2021 to $4.2 million in Q3 2021, reflecting a $424,000 increase in operating expenses [23] - Non-GAAP net loss in Q3 2021 was $3.4 million, up from $2.7 million in Q3 2020, indicating a $606,000 increase in non-GAAP operating expenses [26] Business Line Data and Key Metrics Changes - The company reported an increase in R&D expenses to $2.2 million in Q3 2021, up by $163,000 from Q2 2021, primarily due to amortization expenses related to new tools [26] - General and administrative expenses increased by $315,000 year-over-year, mainly due to higher legal expenses for patent filings [25] Market Data and Key Metrics Changes - The total IC market is forecasted to grow by 24% in 2021, indicating strong demand and investment in semiconductor technologies [9] - Industry CapEx growth in the next five years is expected to be 60% higher than the previous five years, driven by significant investments from major players [9] Company Strategy and Development Direction - The company aims to leverage the current semiconductor supply shortages to promote its MST technology, which is expected to be adopted more readily as companies invest in new fabs [10][12] - Atomera is focusing on expanding its customer base through joint development agreements (JDAs) and enhancing its patent portfolio, which has grown to 298 patents issued and pending worldwide [20][21] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the semiconductor industry's investment cycle, which is expected to create opportunities for MST adoption [21] - The company noted that customer engagement has been positive, with many customers eager to start work with MST technology despite current supply constraints [12][13] Other Important Information - The company has finalized the acceptance of a new Epi deposition tool, which will enhance its capabilities in delivering MST wafers to customers [19] - Cash balance as of September 30, 2021, was $31.8 million, down from $34.3 million at the end of Q2 2021, reflecting cash used in operating activities [27] Q&A Session Summary Question: What is driving the expanded pipeline in JDAs? - The expansion is driven by interest in key technologies like RF-SOI and MST SP, with customers wanting to start work ahead of the capacity crunch ending [32][33] Question: How do you characterize the phases of new JDAs? - There is a mix of customers in different phases, with some in Phase 3 and others in Phase 1 [35][36] Question: What is the expected timeline for moving to Phase 5? - The timeline is difficult to predict, but once the JDA is completed, it could take about nine months to move into production [57] Question: How does the fab build-out impact Atomera? - The build-out presents opportunities for Atomera as companies will need to differentiate and maximize capacity utilization, which MST can help achieve [50][52] Question: What is the motivation for hiring a PR firm? - The PR firm is intended to expand outreach beyond foundries and IDMs to fabless players, enhancing visibility in the market [53][54] Question: How long is the anticipated royalty stream? - The company expects to negotiate royalty streams that could last for eight to ten years or more, similar to industry practices [63]

Atomera Incorporated (NASDAQ:ATOM) Q2 2021 Earnings Conference Call August 3, 2021 5:00 PM ET Company Participants Mike Bishop – Investor Relations. Scott Bibaud – President and Chief Executive Officer Frank Laurencio - Chief Financial Officer Conference Call Participants Richard Shannon – Craig-Hallum Mike Bishop Hello, everyone, and welcome to Atomera's Second Quarter Fiscal Year 2021 Earnings Call. I'd like to remind everyone that this call and webinar are being recorded, and a replay will be available ...

Revenue and Financial Performance - Revenue for the six months ended June 30, 2021, was approximately $400,000, compared to $62,000 for the same period in 2020, representing a significant increase [67]. - Net cash used in operating activities for the six months ended June 30, 2021, was approximately $6.6 million, primarily due to a net loss of approximately $7.3 million [74]. Operating Expenses - Operating expenses for the three months ended June 30, 2021, totaled approximately $3.7 million, slightly down from $3.8 million in the same period in 2020 [69]. - Research and development expenses for the six months ended June 30, 2021, were approximately $4.3 million, an increase of approximately $150,000 compared to $4.1 million in 2020 [70]. - General and administrative expenses for the six months ended June 30, 2021, were approximately $3.0 million, up from $2.9 million in 2020, reflecting an increase of approximately $94,000 [71]. - Selling and marketing expenses for the six months ended June 30, 2021, were approximately $403,000, a decrease of approximately $37,000, or 8%, compared to $440,000 in 2020 [72]. Cash Position - As of June 30, 2021, the company had cash and cash equivalents of approximately $34.3 million and working capital of approximately $33.9 million [76]. Future Outlook and Strategy - The company expects to generate increased fees from licensing agreements and royalties from customer sales of products incorporating MST technology in the future [65]. - The company has a commercialization strategy focused on licensing MST technology to foundries, IDMs, and fabless semiconductor manufacturers [63]. - Future capital requirements will depend on the successful commercialization of MST technology and the need for collaborations or acquisitions to enhance current offerings [77].

Company Overview - Atomera's Mears Silicon Technology (MST) enhances semiconductors for higher performance, lower power, and lower costs[5] - The company is engaged with 50% of the world's top semiconductor makers[5,18] - Atomera has licenses with four companies, including a recent Joint Development Agreement (JDA)[5] Technology and Benefits - MST improves efficiency with higher transistor performance, lower power consumption, and better reliability[7] - MST can lower costs through reduced die size, improved yield, and higher throughput[8] - MST provides a 30% performance advantage[33,34] and enables a die shrink of 15-20%[33] Customer Engagement and Revenue - Atomera is working with 19 customers across 25 engagements[18] - Adoption of MST in one fab can make Atomera profitable from royalties alone, with 2021 non-GAAP OPEX guidance of $14000000-14500000[19] - A worldwide average fab with a monthly capacity of 49000 wafers has an annual revenue potential of $13000000 at a 2% royalty rate[20] - A leading foundry 28nm fab with a monthly capacity of 80000 wafers has an annual revenue potential of $58000000 at a 2% royalty rate[20] Financials - Atomera's Q1 2021 revenue was $400000[27] - The company's net loss for Q1 2021 was ($3600000)[27] - Atomera's cash balance as of March 31, 2021, was $36700000[27]

Atomera's Technology and Business Model - Mears Silicon Technology (MST) enhances semiconductors, leading to higher performance, lower power, and lower costs for ICs[5] - Atomera operates a capital-light IP and technology licensing business with a growing patent portfolio[5] - The company is engaged with 50% of the world's top semiconductor makers[5,19] - Atomera has licenses with four companies, including a recent Joint Development Agreement (JDA)[5] Customer Engagement and Revenue - Atomera's customer engagement model involves phases from planning to production, generating revenue through engineering service fees, license fees, and royalties[17,18] - The company is working with 19 customers across 25 engagements[19] Royalty Opportunity and Market Potential - With approximately 370 wafer fabs operating worldwide, MST adoption in one fab could make Atomera profitable from royalties alone[20] - A worldwide average fab with a monthly capacity of 49,000 wafers could generate $13 million in annual revenue at a 2% royalty rate[21] - A leading foundry 28nm fab with a monthly capacity of 80,000 wafers could generate $58 million in annual revenue at a 2% royalty rate[21] Financial Performance - Atomera's Q1 2021 revenue was $0.4 million, with a net loss of $3.6 million[28] - The company's non-GAAP OPEX guidance for 2021 is $14.00-14.5 million[20] - As of March 31, 2021, Atomera had $36.7 million in cash and 23.1 million shares outstanding[28] MST Benefits and Applications - MST can provide a 30% performance improvement or a 25% die shrink[23] - MST enables legacy capacity expansion by providing a 30% performance advantage and a 15-20% die shrink[34]

Revenue - Revenue for Q1 2021 was approximately $400,000, a significant increase from $62,000 in Q1 2020, primarily due to a manufacturing license payment under a joint development agreement (JDA) [69]. - The company anticipates increased revenue from licensing agreements and royalties from products incorporating MST technology in the future [67]. - The company has generated revenue through a JDA, licensing agreements with two integrated device manufacturers (IDMs), and engineering services [64]. Operating Expenses - Operating expenses for Q1 2021 totaled approximately $4.0 million, compared to $3.7 million in Q1 2020, reflecting an increase of about 8% in research and development expenses [69]. - Research and development expenses for Q1 2021 were approximately $2.2 million, up from $2.1 million in Q1 2020, driven by additional headcount [72]. - General and administrative expenses for Q1 2021 were approximately $1.5 million, an increase of about 5% from $1.4 million in Q1 2020, mainly due to higher payroll-related expenses [73]. - Selling and marketing expenses for Q1 2021 were approximately $266,000, a decrease of about 18% from $225,000 in Q1 2020, attributed to lower travel expenses [74]. Cash Flow and Financial Position - Net cash used in operating activities for Q1 2021 was approximately $3.9 million, primarily due to a net loss of approximately $3.6 million [76]. - As of March 31, 2021, the company had cash and cash equivalents of approximately $36.7 million and working capital of approximately $36.4 million [78]. - Future capital requirements will depend on the successful commercialization of MST technology and may necessitate raising additional capital if revenue generation does not meet cash needs [79].

Atomera Inc. (NASDAQ:ATOM) Q1 2021 Earnings Conference Call April 28, 2021 5:00 PM ET Company Participants Mike Bishop - Investor Relations Scott Bibaud - President & Chief Executive Officer Francis Laurencio - Chief Financial Officer Conference Call Participants Cody Acree - The Benchmark Company Richard Shannon - Craig-Hallum Mike Bishop Okay, I think we're ready to begin the call. Hello, everyone, and welcome to Atomera's First Quarter Fiscal Year 2021 Earnings Webinar. I'd like to remind everyone that t ...